Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Metabolomics for biomarker discovery in schistosomiasis: A systematic scoping review

Title: Metabolomics for biomarker discovery in schistosomiasis: A systematic scoping review
Authors: Midzi, Herald; Vengesai, Arthur; Muleya, Victor; Kasambala, Maritha; Mduluza-Jokonya, Tariro Lavender; Chipako, Isaac; Siamayuwa, Clayton Edmore; Mutapi, Francisca; Naicker, Thajasvarie; Mduluza, Takafira
Source: Frontiers in Tropical Diseases ; volume 4 ; ISSN 2673-7515
Publisher Information: Frontiers Media SA
Publication Year: 2023
Collection: Frontiers (Publisher - via CrossRef)
Description: Background Metabolomic based approaches are essential tools in the discovery of unique biomarkers for infectious diseases via high-throughput global assessment of metabolites and metabolite pathway dysregulation. This in-turn allows the development of diagnostic tools and provision of therapeutics. In this review, we aimed to give an overview of metabolite biomarkers and metabolic pathway alterations during Schistosoma haematobium and Schistosoma mansoni infections. Methods We conducted the review by systematically searching electronic databases and grey literature to identify relevant metabolomics studies on schistosomiasis. Arksey and O’Malley methodology for conducting systematic scoping reviews was applied. A narrative summary of results was conducted following the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for scoping review guidelines. Results Twelve articles included in the review identified 127 metabolites, whose concentrations were considerably altered during S. mansoni and S. haematobium infections. The metabolites were assigned to metabolic pathways involved in energy (34.6%), gut microbial (11.0%), amino acid (25.2%), nucleic acids (6.3%), immune proteins (8.7%) hormones (2.4%) and structural proteins/lipids (11.8%). Energy related metabolic pathways were the most affected during schistosome infections with metabolites such as succinate, citrate, aconitate and fumarate of the tricarbocylic acid cycle being significantly altered in organ, serum and plasma samples. Amino acid metabolism was also impacted during schistosome infections as phenylacetylglycine, alanine, taurine, 2-oxoisocaproate and 2-oxoisovalerate emerged as potent biomarkers. Elevated structural proteins such as actin, collagen and keratin concentrations were identified as biomarkers of liver fibrosis, a common pathological feature in chronic schistosomiasis infections. Hippurate was a major metabolite biomarker in the gut microbial related pathway. Conclusions The analysis of the literature revealed ...
Document Type: article in journal/newspaper
Language: unknown
DOI: 10.3389/fitd.2023.1108317
DOI: 10.3389/fitd.2023.1108317/full
Availability: https://doi.org/10.3389/fitd.2023.1108317; https://www.frontiersin.org/articles/10.3389/fitd.2023.1108317/full
Rights: https://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.95EEC982
Database: BASE